Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Pharmaceutical Technology
pharmaceutical-technology.com-technology.com

Updated UK guidance for finerenone introduces new treatment for HF patients

4+ hour, 8+ min ago   (73+ words) pharmaceutical-technology.com Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends. With a free Pharmaceutical Technology profile, you can: - View premium forecasts and data-driven…...

scr.zacks.com
scr.zacks.com > news > news-details > 2026 > ACHV-Looking-Ahead-to-Resubmission-article > default.aspx

ACHV: Looking Ahead to Resubmission

16+ min ago   (217+ words) READ THE FULL ACHV RESEARCH REPORT New Executive and Board Members Added Data Presentation at the American Thoracic Society Meeting Principal investigator Nancy Rigotti, MD, presented Ongoing Research of Cytisinicline for Addiction Open Label (ORCA OL) data at the American…...

Dealroom.co
app.dealroom.co > news > note > midfirst-bank-takes-new-810k-stake-in-gilead-sciences

Dealroom.co | MidFirst Bank takes new $810K stake in Gilead Sciences

3+ hour, 23+ min ago   (245+ words) What's the deal? MidFirst Bank acquired a new position in Gilead Sciences worth roughly $810,000 in the second quarter, buying 6,414 shares of the biopharmaceutical company. The disclosure came in the bank's latest 13F filing with the Securities and Exchange Commission. What the…...

Clinical Trials Arena
clinicaltrialsarena.com > news > leal-30m-fund-schizophrenia-als-trials

Leal Therapeutics raises $30m to fund schizophrenia and ALS trials

6+ hour, 36+ min ago   (312+ words) Proceeds from the investment will enable Leal Therapeutics to proceed with an initial data readout from LTX-001. Leal Therapeutics has completed a $30m extension of its Series A financing to support advancement of its investigational therapies for schizophrenia and amyotrophic lateral…...

@pharma_indian
indianpharmapost.com > news > hearzap-completes-acquisition-of-amplifon-indias-hearing-healthcare-business-21423

Hearzap completes acquisition of Amplifon India’s hearing healthcare business

6+ hour, 55+ min ago   (295+ words) Hearzap has completed the acquisition of Amplifon India’s hearing healthcare business, following the definitive agreement announced in May 2026, in a transaction that significantly expands its presence in India’s organised hearing healthcare sector. Backed by investor 360 ONE Asset Management, Hearzap will…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > m-rieux-nutrisciences-enters-agreement-140000762.html

Mérieux NutriSciences Enters Agreement to Acquire Certified Group

37+ min ago   (611+ words) Mérieux NutriSciences, a leading provider of solutions for food safety, quality, and sustainability, announced today that it has entered into an agreement to acquire Certified Group. This strategic acquisition reinforces the company's commitment to delivering highly practical, innovative solutions to…...

Google News
manilatimes.net > 08/18/2026 > tmt-newswire > globenewswire > dar-bioscience-ceo-sabrina-martucci-johnson-named-to-forbes-2026-50-over-50-innovation-list > 2407650

DAR?? Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 "50 Over 50: Innovation??? List

1+ hour, 21+ min ago   (586+ words) Ms. Johnson’s recognition comes during a potentially transformative period for Daré as the company works to evolve from a predominantly clinical-stage biotechnology company into a multi-product women’s health company with commercial revenue opportunities alongside a differentiated development pipeline. Among the…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > life-couriers-gains-ceo-sale-122516957.html

Life Couriers gains new CEO with sale to private equity firm

2+ hour, 12+ min ago   (239+ words) Munich, Germany-based Life Couriers, a provider of expedited and temperature-controlled logistics services with a core competence in the healthcare sector, has been acquired by private equity firm JLL Partners, the companies announced on Monday. Other large logistics companies are actively…...

WKZO
wkzo.com > 08/18/2026 > amylyx-drug-cuts-low-blood-sugar-episodes-in-bariatric-surgery-patients-in-key-trial

Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial

47+ min ago   (270+ words) Aug 18 (Reuters) – Amylyx Pharmaceuticals’ experimental drug met its main goal in a late-stage trial for post-bariatric hypoglycemia, a condition marked by dangerously low ​blood sugar levels following weight-loss surgery, sending ‌its shares up over 30% in premarket trading on Tuesday. In…...

International Business Times
ibtimes.com.au > amylyx-pharmaceuticals-shares-surge-avexitide-trial-results-1874249

Amylyx Pharmaceuticals Stock Soars 48% After Avexitide Hits All Endpoints in Pivotal Phase 3 Trial

28+ min ago   (746+ words) International Business Times Australia...